Wong D L, Adams S G, Irish J C, Durkin L C, Hunt E J, Charlton M P
Department of Otolaryngology, Toronto Hospital, Ontario.
J Otolaryngol. 1995 Aug;24(4):209-16.
Spasmodic dysphonia (SD), a neurologic disorder characterized by involuntary vocal spasms during speech, has been effectively treated by injections of botulinum toxin (BT) into the laryngeal muscles. The aim of the present study was to determine if the therapeutic response to BT is enhanced by immediate and continuous activation of the injected muscles. Twenty SD patients were randomized into two groups following bilateral injections: vocal rest for 30 minutes and continuous vocalization for 30 minutes. Evaluations consisted of voice ratings by expert observers, acoustic measurements using computer analyses, and laryngeal aerodynamic measurements. The findings suggest that vocal rest, rather than vocalization, produces a superior and longer lasting response in SD patients receiving BT injections. It is recommended that SD patients refrain from post-injection vocalization to maximize the therapeutic effects of BT.
痉挛性发声障碍(SD)是一种神经系统疾病,其特征是在说话时出现非自愿性的声带痉挛,通过向喉部肌肉注射肉毒杆菌毒素(BT)已得到有效治疗。本研究的目的是确定注射肌肉的立即和持续激活是否会增强对BT的治疗反应。20名SD患者在双侧注射后被随机分为两组:30分钟的声带休息和30分钟的持续发声。评估包括专家观察者的语音评分、使用计算机分析的声学测量以及喉部空气动力学测量。研究结果表明,在接受BT注射的SD患者中,声带休息而非发声会产生更好且更持久的反应。建议SD患者在注射后避免发声,以最大限度地提高BT的治疗效果。